C/EBPβ enhances platinum resistance of ovarian cancer cells by reprogramming H3K79 methylation
In ovarian cancer, the mechanism of chemoresistance is a key question. Here, the authors demonstrate that C/EBPβ and DOT1L together increase methylation of H3K79, which upregulates expression of oncogenic genes and drives poor platinum response and poor survival in ovarian cancer.
Saved in:
Main Authors: | Dan Liu, Xiao-Xue Zhang, Meng-Chen Li, Can-Hui Cao, Dong-Yi Wan, Bi-Xin Xi, Jia-Hong Tan, Ji Wang, Zong-Yuan Yang, Xin-Xia Feng, Fei Ye, Gang Chen, Peng Wu, Ling Xi, Hui Wang, Jian-Feng Zhou, Zuo-Hua Feng, Ding Ma, Qing-Lei Gao |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/c9b30596b94249a2a0f1f7ff2dd6da2e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platinum–copper single atom alloy catalysts with high performance towards glycerol hydrogenolysis
by: Xi Zhang, et al.
Published: (2019) -
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
by: Laura Godfrey, et al.
Published: (2019) -
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
by: You Jiang, et al.
Published: (2021) -
Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients
by: Rong Liu, et al.
Published: (2017) -
Evidence that ubiquitylated H2B corrals hDot1L on the nucleosomal surface to induce H3K79 methylation
by: Linjiao Zhou, et al.
Published: (2016)